Nerve Block of the Proximal Interphalyngeal Joints PIPs in Rheumatoid Arthritis (RA) Patients: a Prospective Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- Change in pain
研究概览
简要总结
Researchers will include 83 rheumatoid arthritis patients (either early or established) diagnosed after 2010 ACR/EULAR criteria with bilateral hand arthritis aged 18 or above. Nerve block to the neural bundle of the 2nd and 3rd PIPs will be done to one hand (the dominant in half of the participants and the non-dominant in the remaining). The other hand will be used as a control and injected subcutaneously with saline. Half ml of Bupivacaine will be injected through a 27G needle at the level of the volar proximal digital crease of the 2nd and 3rd PIP. The needle will be directed alternatively toward the two pedicles on both sides.
PIPs of the 2nd and 3rd fingers in both hands will be examined EULAR-OMERACT scoring system at 0, 2 weeks, and 2 months intervals. Visual analog scale (VAS) for each hand will be used at the same intervals. There are no certain conditions for medications and all the patients were using sDMARDS.
详细描述
PIPs of the 2nd and 3rd fingers at the control group will be injected with .5 mL of saline on each joint through a 27G needle.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Rheumatoid arthritis patient according to ACR/EULAR criteria
- •bilateral hand affection
排除标准
- •peripheral neuropathy
- •other chronic arthritis
- •patient who did mastectomy or any other hand operation
研究组 & 干预措施
Bupivacine injected
Half ml of Bupivicaine hydrochloride .5% (Marcaine, Pfizer) was injected through a 27G needle at the level of the volar proximal digital crease of the 2nd and 3rd PIP on each side of the selected joint.
干预措施: Nerve block (Drug)
Control group
Saline was injected subcutaneously in the 2nd and 3rd PIP on each side of the selected joint.
干预措施: Saline injection (Drug)
结局指标
主要结局
Change in pain
时间窗: 0 time after 2 weeks and after 2 months
by visual analogue sclae
Change in the degree of inflammation
时间窗: at 0 time after 2 weeks and after 2 months
Musculoskeletal ultrasound evaluation by EULAR-OMERACT score
次要结局
未报告次要终点
研究者
Ahmed Mahrous
Associate professor
Sohag University
